Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Aesica and CMIC Sign Collaborative Agreement

Published: Thursday, October 17, 2013
Last Updated: Thursday, October 17, 2013
Bookmark and Share
Memorandum of Understanding between the two companies will identify reciprocal consultation and manufacturing opportunities for clients in Japan and Europe whilst enabling joint collaborative development in the US.

Aesica Pharmaceuticals Limited and CMIC HOLDINGS Co., Ltd. have announced the signing of a Memorandum of Understanding for the reciprocal development of sales and marketing opportunities for respective clients in Europe and Japan.

Furthermore, both companies will work closely together to develop commercial opportunities across the US market.

Under the terms of the Memorandum of Understanding on collaborative agreement, Aesica and CMIC will exploit corporate synergies between the two companies and form a very close working relationship through which a collaborative approach to sales and marketing and customer liaison is set to be developed for the benefit of their customers. This initiative will form the initial basis of a supply and quality agreement.

Specifically, the reciprocal marketing of capabilities will be used by Aesica to proactively seek expansion of business opportunities in Japan and the US, collaborating with CMIC customers who may require consultation and manufacturing in Europe.

Equally, CMIC is looking to expand global commercial business opportunities outside of the Japanese market, collaborating with Aesica customers who may require consultation or manufacturing in Japan. Additionally, both parties will pursue joint collaborative development of the US market.

Dr Robert Hardy, CEO of Aesica commented: “This agreement will provide a tremendous opportunity to develop business and commercial opportunities for our customers in the Japanese market and in the US, whilst providing solid scope for us to expand our market share in these regions. We look forward to forging an extremely close working relationship and partnership between our two companies”.

Kazuo Nakamura, Chairman and CEO of CMIC added: “There are tremendous synergies between CMIC and Aesica which will be exploited to the full commercial benefit of customers of each company. Whilst CMIC is a leading Japanese, full service contract development and manufacturer of formulated products for the pharmaceutical industry, with established manufacturing sites in Japan, Korea and the USA, Aesica is an international CDMO operating in the UK, Germany and Italy across both API and formulated products. The combined, European, Japanese and US commercial expertise and presence is enormous.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Aesica Concentrates Investment in Lucrative German Formulations Business
Zwickau site introduces roller compaction unit for dry granulation production.
Saturday, July 12, 2014
Aesica Announces Collaboration with QRxPharma
Agreement for the worldwide promotion of Stealth Beadlets® abuse deterrence technology.
Tuesday, July 23, 2013
Scientific News
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Computerized Flexible Needles Prove Themselves in Biological Tissue
The advantage of the system is that you can avoid obstacles with the needles or critical tissues and that the system during the insertion of the needle in real time can adjust the path if, for example, the tissue deforms.
DARWIN 2 24-week Monotherapy Data in RA Confirm Previous Results
Safety profile in DARWIN 2 consistent with previous filgotinib RA studies.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Overdose of Vitamin D in Teenagers May Lead to Increased Cholesterol Levels
Dosing obese teens with vitamin D shows no benefits for their heart health or diabetes risk, and could have the unintended consequences of increasing cholesterol and fat-storing triglycerides. These are the latest findings in a series of Mayo Clinic studies in childhood obesity.
Phase 2 Trials Underway for New Single Dose Malaria Treatment
The new drug, which prevents the malaria parasite from reproducing and spreading, is now undergoing Phase II clinical trials in humans.
Promising Drug for Parkinson's Disease
A drug which has already been in use for decades to treat liver disease could be an effective treatment to slow down progression of Parkinson’s disease, scientists from the University of Sheffield have discovered.
Benefits of Early Antiretroviral Therapy in HIV Infection
Scientists have explored the clinical importance of starting treatment early in individuals suffering with HIV.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!